Nathan Stebbins

Venture investor in Los Angeles

Invests in AI

Nathan Stebbins's investor profile lists AI alongside Biotech & Pharma and Healthcare & Biotech, at early-stage venture and Series A. The record holds 54 deals, among them KSQ Therapeutics, Denali Therapeutics and Syros Pharmaceuticals.

Email Investor

Email Investor

Credits to line up before an early-stage round

Nathan Stebbins backs companies at early-stage venture and Series A. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • KSQ Therapeutics
  • Denali Therapeutics
  • Syros Pharmaceuticals
  • Incredible Foods
  • Inzen Therapeutics
  • Ohana Biosciences
  • T2 Biosystems
  • Tangent Medical Technologies
  • Kaleido BioSciences
  • Permeon Biologics
  • Kovio
  • Oasys Water
  • Editas Medicine
  • Tessera Therapeutics
  • Ring Therapeutics
  • Moderna Therapeutics
  • Omega Therapeutics
  • Cygnal Therapeutics
  • Sana Biotechnology
  • Seres Therapeutics
  • Agios Pharmaceuticals
  • Red Rock Biofuels
  • Tarveda Therapeutics
  • Receptos
  • Repertoire Immune Medicines
  • Generate Biomedicines
  • Codiak Biosciences
  • BlackDuck
  • Polatis
  • Seventh Sense Biosystems
  • Sigilon Therapeutics
  • Boragen
  • TARIS Biomedical
  • TransMedics
  • Selecta Biosciences
  • Quanterix
  • Visterra
  • Sesen Bio, Inc.
  • CiBO Technologies
  • medidametrics
  • Rubius Therapeutics
  • Axcella
  • Senda Biosciences
  • Foghorn Therapeutics
  • Evelo Biosciences
  • Inari
  • Joule Unlimited Technologies
  • Cellarity
  • WikiCell Designs
  • Avedro

Showing 50 of 54 deals on record.

Investment focus

Backs startups in
Artificial Intelligence, Biotech & Pharma, Healthcare & Biotech
Rounds
Early-stage venture, Series A
Profile
Venture investor
Deals on record
54
Based in
Los Angeles, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Nathan Stebbins invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Nathan Stebbins's investor profile, together with Biotech & Pharma and Healthcare & Biotech. The stages on record are early-stage venture and Series A.
Which companies has Nathan Stebbins backed?
The record lists 54 deals, including KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and Inzen Therapeutics. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Nathan Stebbins?
For a company raising an early-stage round, AI Perks lists credits such as GitLab (up to $12,000), Gemini (up to $350,000), Appwrite (up to $20,000) and Massdriver (up to $20,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor